Considerable evidence has been accumulated to indicate that the liver is concerned in the metabolism of steroids (1). The development of methods for the measurement of 17-hydroxycorticosteroids in the plasma (2) and in the urine (3) has enabled us to study the role of the liver in the handling of 17-hydroxycorticosterone (hydrocortisone) and related compounds. This communication will consider the plasma levels and the urinary excretion of the 17-hydroxycorticoids in patients with liver disease as compared with a group of normal subjects.
MATERIALS AND METHODSTwelve patients with liver disease and eleven normal subjects were studied. Of the twelve patients with liver disease, there were nine with cirrhosis, two with hepatitis and one with metastatic carcinoma. Serial studies were carried out in the patients with hepatitis to note the effects of improvement in liver function. The "normal subjects" were hospital personnel or convalescing hospital patients who were free of liver disease, fever, and endocrine abnormalities.These subjects were given intravenously a solution containing 0.02 per cent hydrocortisone (free alcohol), 5 per cent dextrose and 1 per cent alcohol. A sufficient quantity of this commercially-prepared solution.2 was administered to give the subject 1 mg. of hydrocortisone for each kilogram of body weight.Control bloods were drawn shortly after 8 A.M., following which the infusion was administered over a 30-minute period. Blood samples for the estimation of the 17-hydroxycorticosteroid level of the plasma were drawn at 1, 2, 4, and 6 hours after the beginning of the infusion. After the infusion, the subjects were allowed to have breakfast and to be up and about, if they were ambulatory.The plasma was separated within two hours and stored in a frozen state until the analysis could be carried out. The estimation of the plasma 17-hydroxycorticosteroid